Company profile: PMOD Technologies
1.1 - Company Overview
Company description
- Provider of software quantification tools for biomedical imaging in humans and animals. PMOD software originated in 1993, developed at the University Hospital PET Center in Zurich when PET was mainly a research tool, and was adopted by the PET community.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PMOD Technologies
Nonlinear Dynamics
HQ: United Kingdom
Website
- Description: Provider of scientific software for proteomics, metabolomics, genomics, drug discovery, and bioinformatics, including Progenesis QI for LC-MS analysis of small molecules, Progenesis QI for Proteomics for label-free LC-MS protein quantification and identification, and the Natural Product Atlas Library with structural data on microbially derived natural products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nonlinear Dynamics company profile →
HotSpot Therapeutics
HQ: United States
Website
- Description: Provider of the Smart Allostery Platform to identify hotspots and design allosteric modulators by integrating biology, computational sciences, chemistry and biophysics; with programs: HST-1011, an investigational oral allosteric CBL-B inhibitor in Phase 1 for solid tumors, and HST-1021, a potential first-in-class MALT1 scaffolding inhibitor for hematological malignancies and selected solid tumors with preclinical tumor growth inhibition.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full HotSpot Therapeutics company profile →
Schrödinger
HQ: United States
Website
- Description: Provider of physics-based molecular discovery and design software platforms for therapeutics and materials research, supporting biopharmaceutical and industrial companies, academic institutions, and government labs; offers collaborative and wholly-owned drug discovery programs and pipeline, educational resources and courses, and tools to model and optimize metals, alloys, and ceramics via computational workflows and machine learning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Schrödinger company profile →
Imprint
HQ: United States
Website
- Description: Provider of forensic immunology research tools that are scalable, cost-efficient, and accessible to the biomedical community.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Imprint company profile →
Author-it
HQ: United States
Website
- Description: Provider of enterprise software for authoring, content management, publishing, and localization, including Author-it CCMS for creating, managing, and multi-channel publishing of technical documentation and eLearning; Docuvera for structured authoring in life sciences and pharmaceutical industries; cloud-based eLearning authoring with xAPI/SCORM and LMS integration; plus support, implementation, and consulting services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Author-it company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PMOD Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PMOD Technologies
2.2 - Growth funds investing in similar companies to PMOD Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PMOD Technologies
4.2 - Public trading comparable groups for PMOD Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →